Central African Republic vs World: Hepatitis B surface antigen (HBsAg) prevalence
Central African Republic
5.3%
in 2024
World
0.6%
in 2024
Central African Republic rank
1st
World rank
3rd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Central African Republic
- World
How they compare
Central African Republic currently reports 5.3% against 0.6% in World, a difference of 4.7%.
That makes Central African Republic's figure about 8.8 times World's.
Across all 10 years both countries report, Central African Republic has been ahead every year.
Central African Republic ranks 1st and World ranks 3rd of 194 countries.
Central African Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | World | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 10.0% | 0.7% | 9.3% | Central African Republic |
| 2020s | 7.0% | 0.6% | 6.3% | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Central African Republic or World?
- Central African Republic, at 5.3% against 0.6% in World as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Central African Republic and World?
- 4.7%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and World?
- 10 years are reported by both, from 2015 to 2024.
- How do Central African Republic and World rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Central African Republic ranks 1st and World ranks 3rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.